TRIM21 and ocular melanoma: Thus, both OM subsets were similar with respect to the frequencies of antisynthetase autoantibodies (35% vs 28%, respectively), anti-Ro52/TRIM21 autoantibodies (30% vs 35%, respectively), and cancer (0% in each subset) (see Table 6).